• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青蒿素及其衍生物:一类新型的抗疟和抗癌药物。

Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents.

机构信息

Natural Products Chemistry Division, North-East Institute of Science & Technology, Assam, Jorhat-785006, India.

出版信息

Chem Soc Rev. 2010 Feb;39(2):435-54. doi: 10.1039/b816679j. Epub 2009 Aug 24.

DOI:10.1039/b816679j
PMID:20111769
Abstract

In this tutorial review, an effort towards presentation of a comprehensive account of the recent developments on various kinds of artemisinin derivatives including artemisinin dimers, trimers and tetramers has been made and their efficacy towards malaria parasites and different cancer cells lines was compared with that of artemisinins, and various other anti-malarial and anti-cancer drugs. It is expected that this review will provide first-hand information on artemisinin chemistry to organic/medicinal chemists, and pharmacologists working on anticancer and anti-malarial drug development.

摘要

在本教程综述中,我们努力全面介绍各种青蒿素衍生物的最新发展情况,包括青蒿素二聚体、三聚体和四聚体,并将其对疟原虫和不同癌细胞系的疗效与青蒿素以及其他各种抗疟药和抗癌药进行了比较。我们希望本综述能为从事抗癌和抗疟药物开发的有机/药物化学家以及药理学家提供有关青蒿素化学的第一手信息。

相似文献

1
Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents.青蒿素及其衍生物:一类新型的抗疟和抗癌药物。
Chem Soc Rev. 2010 Feb;39(2):435-54. doi: 10.1039/b816679j. Epub 2009 Aug 24.
2
Synthesis and biological evaluation of extraordinarily potent C-10 carba artemisinin dimers against P. falciparum malaria parasites and HL-60 cancer cells.针对恶性疟原虫和HL-60癌细胞的超强C-10碳青霉烯青蒿素二聚体的合成及生物学评价
Bioorg Med Chem. 2009 Feb 1;17(3):1325-38. doi: 10.1016/j.bmc.2008.12.017. Epub 2008 Dec 24.
3
Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers with high stability and efficacy.具有高稳定性和疗效的口服活性、抗疟疾、抗癌的青蒿素衍生三氧杂环丁烷二聚体。
J Med Chem. 2003 Mar 13;46(6):1060-5. doi: 10.1021/jm020461q.
4
Antimalarial and antitumor evaluation of novel C-10 non-acetal dimers of 10beta-(2-hydroxyethyl)deoxoartemisinin.新型10β-(2-羟乙基)脱氧青蒿素C-10非缩醛二聚体的抗疟和抗肿瘤评价
J Med Chem. 2004 Feb 26;47(5):1290-8. doi: 10.1021/jm030974c.
5
Antitumour and antimalarial activity of artemisinin-acridine hybrids.青蒿素-吖啶杂合物的抗肿瘤和抗疟活性。
Bioorg Med Chem Lett. 2009 Apr 1;19(7):2033-7. doi: 10.1016/j.bmcl.2009.02.028. Epub 2009 Feb 11.
6
Anticancer and antimalarial efficacy and safety of artemisinin-derived trioxane dimers in rodents.青蒿素衍生的三氧烷二聚体在啮齿动物中的抗癌和抗疟功效及安全性
J Med Chem. 2004 Feb 26;47(5):1299-301. doi: 10.1021/jm0303711.
7
Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation.青蒿素衍生物的抗癌特性及其通过转铁蛋白偶联实现的靶向递送
Int J Pharm. 2008 Apr 16;354(1-2):28-33. doi: 10.1016/j.ijpharm.2007.09.003. Epub 2007 Sep 6.
8
Recent advances in artemisinin and its derivatives as antimalarial and antitumor agents.青蒿素及其衍生物作为抗疟和抗肿瘤药物的最新进展。
Curr Med Chem. 2004 May;11(10):1265-84. doi: 10.2174/0929867043365233.
9
Antimalarial activities of (+)-deoxoartemisitene and its novel C-11, 13 derivatives.(+)-脱氧青蒿烯及其新型C-11、13衍生物的抗疟活性。
Bioorg Med Chem Lett. 2004 Apr 19;14(8):2001-3. doi: 10.1016/j.bmcl.2003.12.104.
10
Artemisinin and Derivatives-Based Hybrid Compounds: Promising Therapeutics for the Treatment of Cancer and Malaria.青蒿素及其衍生物类杂合物:治疗癌症和疟疾的有前途的治疗药物。
Molecules. 2021 Dec 11;26(24):7521. doi: 10.3390/molecules26247521.

引用本文的文献

1
Artemisinin synergizes with CCCP in autophagic cell death induction via ER stress in uveal melanoma.青蒿素与羰基氰氯苯腙(CCCP)协同作用,通过内质网应激诱导葡萄膜黑色素瘤细胞发生自噬性细胞死亡。
iScience. 2025 Jun 21;28(8):112972. doi: 10.1016/j.isci.2025.112972. eCollection 2025 Aug 15.
2
Bibliometric and Visualized Analysis of Artemisinin and Its Derivatives in Cancer.青蒿素及其衍生物在癌症研究中的文献计量学与可视化分析
Drug Des Devel Ther. 2025 Jun 30;19:5517-5538. doi: 10.2147/DDDT.S514219. eCollection 2025.
3
The plant matrix of Artemisia annua L. for the treatment of malaria: Pharmacodynamic and pharmacokinetic studies.
用于治疗疟疾的青蒿植物基质:药效学和药代动力学研究。
PLoS One. 2025 May 7;20(5):e0322835. doi: 10.1371/journal.pone.0322835. eCollection 2025.
4
Artesunate Inhibits Neointimal Hyperplasia by Promoting IRF4 Associated Macrophage Polarization.青蒿琥酯通过促进与IRF4相关的巨噬细胞极化来抑制内膜增生。
Adv Sci (Weinh). 2025 May;12(19):e2408992. doi: 10.1002/advs.202408992. Epub 2025 Mar 24.
5
Targeting Ferroptosis: Small-molecule Inducers as Novel Anticancer Agents.靶向铁死亡:小分子诱导剂作为新型抗癌药物
Anticancer Agents Med Chem. 2025;25(8):517-532. doi: 10.2174/0118715206342278241008081126.
6
Artemisinin inhibits neuronal ferroptosis in Alzheimer's disease models by targeting KEAP1.青蒿素通过靶向KEAP1抑制阿尔茨海默病模型中的神经元铁死亡。
Acta Pharmacol Sin. 2025 Feb;46(2):326-337. doi: 10.1038/s41401-024-01378-6. Epub 2024 Sep 9.
7
Persianolide-A, an eudesmanolide-type sesquiterpene lactone from , induces apoptosis by regulating ERK signaling pathways.波斯内酯-A,一种从[来源未提及]中提取的桉叶烷型倍半萜内酯,通过调节ERK信号通路诱导细胞凋亡。
Res Pharm Sci. 2024 Jul 1;19(3):328-337. doi: 10.4103/RPS.RPS_175_23. eCollection 2024 Jun.
8
Artemisinic acid attenuates osteoclast formation and titanium particle-induced osteolysis via inhibition of RANKL-induced ROS accumulation and MAPK and NF-κB signaling pathways.青蒿酸通过抑制RANKL诱导的活性氧积累以及丝裂原活化蛋白激酶(MAPK)和核因子κB(NF-κB)信号通路,减轻破骨细胞形成和钛颗粒诱导的骨溶解。
Front Pharmacol. 2024 May 1;15:1345380. doi: 10.3389/fphar.2024.1345380. eCollection 2024.
9
Progress of medicinal plants and their active metabolites in ischemia-reperfusion injury of stroke: a novel therapeutic strategy based on regulation of crosstalk between mitophagy and ferroptosis.药用植物及其活性代谢产物在中风缺血再灌注损伤中的研究进展:基于调控线粒体自噬与铁死亡之间相互作用的新型治疗策略
Front Pharmacol. 2024 Apr 8;15:1374445. doi: 10.3389/fphar.2024.1374445. eCollection 2024.
10
Design, Synthesis, and Antitumor Activity Evaluation of Artemisinin Bivalent Ligands.设计、合成双青蒿素配体及其抗肿瘤活性评价。
Molecules. 2024 Jan 15;29(2):409. doi: 10.3390/molecules29020409.